Treatment of neurodegenerative diseases with neural cell transplantation

Bibliography

• DUNNETT SB: Functional repair of striatal systems by neural transplants: evidence for circuit reconstruc-tion. Behaviour. Brain Res. (1995) 66 (1-2) :133–142.
   PubMed Web of Science ®Google Scholar
• FREED WJ: Neural transplantation: prospects for clini-cal use. Cell Transplant. (1993) 2:13–31.
   Web of Science ®Google Scholar
• BJORKLUND A: Neural transplantation - an experimen-tal tool with clinical possibilities. Trends Neurosci. (1991) 14(8):319–322.
   PubMed Web of Science ®Google Scholar
• GAGE FH, FISHER LJ: Intracerebral grafting: a tool for the neurobiologist. Neuron (1991) 6:1–12.
   PubMed Web of Science ®Google Scholar
• OLANOW CW, KORDOWER JH, FREEMAN TB: Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. (1996) 19:102–109.
   PubMed Web of Science ®Google Scholar
• ••A complete and thorough review of both clinical and pre-clinical work in Parkinson's transplantation.
   Google Scholar
• LINDVALL 0, ODIN P: Clinical application of cell trans-plantation and neurotrophic factors in CNS disorders. Curr. Opin. Neurobiol. (1994) 4:752–757.
   PubMedGoogle Scholar
• KORDOWER JH et al.: Dopaminergic transplants in pa-tients with Parkinson's disease: neuroanatomical cor-relates of clinical recovery. Exp. Neurol. (1997) 144:41–46.
   PubMed Web of Science ®Google Scholar
• DEACON TW et al.: Cytoarchitectonic development, axon-glia relationships, and long distance axon growth of porcine striatal xenografts in rats. Exp. Neu-rol. (1994) 130(0:151–67.
   PubMedGoogle Scholar
• ISACSON 0, DEACON TW: Specific axon guidance fac-tors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience (1996) 75:827–837.
   PubMed Web of Science ®Google Scholar
• ISACSON 0 eta].: Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remark-able axonal target specificity and distinct growth pat-terns of glial axonal fibers. Nature Med. (1995) 1:1189–1194.
   Google Scholar
• ••Study showed that correct signals for neurone target selec-tion are maintained in the adult brain.
   Google Scholar
• JACOBY DB et al: Fetal pig neural cells as a restorative therapy for neurodegenerative disease. Artificial Or-gans (1997) 21(10:1192–1198.
   PubMedGoogle Scholar
• PAKZABAN P et al: A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances trans-plant survival in the central nervous system. Neurosci-ence (1995) 65:983–996.
   PubMed Web of Science ®Google Scholar
• ••Cross-species specificity of neuronal outgrowth and targetlocation.
   Google Scholar
• WIDNER H, REHNCRONA S: Transplantation and surgi- cal treatment of Parkinsonian syndromes. Curr. Opin. Neurol Neurosurg. 1993. 6(3):344–349.
   PubMedGoogle Scholar
• WICTORIN K: Anatomy and connectivity of intrastriatal striatal transplants. Prog. Neurobiol. (1992) 38:611–639.
   PubMed Web of Science ®Google Scholar
• WICTORIN K, OUIMET CC, BJORKLUND A: Intrinsic or-ganization and connectivity of intrastriatal striatal transplants in rats as revealed by DARPP-32 immuno-histochemistry: specificity of connections with the le-sioned host brain. Eur. j Neurosci. (1989)1:690–701.
   PubMed Web of Science ®Google Scholar
• ZOMPA EA et al: Transplant therapy: recovery of func-tion after spinal cord injury. J. Neurotrauma (1997) 14 (8):479–506.
   PubMed Web of Science ®Google Scholar
• BAREN-VAN EVERCOOREN A: Future prospects in trans-plantation. Ann. Neurol (1994) 36:S151–S156.
   PubMed Web of Science ®Google Scholar
• DEACON T et al.: Histological evidence of foetal pig neu-ral cell survival after transplantation into a patient with Parkinson's disease. Nature. Med. (1997) 3:350–353.
   PubMed Web of Science ®Google Scholar
• ••First demonstration of surviving xenograft in a human brain.
   Google Scholar
• FREEMAN TB et al.: Bilateral foetal nigral transplanta-tion into the postcommissural putamen in Parkin-son's disease. Ann. Neurol. (1995) 38(3):379–388.
   PubMed Web of Science ®Google Scholar
• KORDOWER JH et al.: Functional foetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ul-trastructural, and metabolic studies. J. Comp. Neurol (1996) 370:203–230.
   PubMed Web of Science ®Google Scholar
• KORDOWER JH et al.: Neuropathological evidence of graft survival and striatal reinnervation after the trans-plantation of foetal mesencephalic tissue in a patient with Parkinson's disease [see comments]. New Engl. J. Merl. (1995) 332(17):1118–1124.
   PubMed Web of Science ®Google Scholar
• ••First ever demonstration of a foetal neural graft in humanbrain.
   Google Scholar
• LINDVALL 0 et al: Evidence for long-term survival and function of dopaminergic grafts in progressive Park- inson's disease. Ann. Neurol. (1994) 35 (2) :172–180.
   PubMed Web of Science ®Google Scholar
• ••Showed that transplanted foetal neurones are not subject todestruction by disease process ongoing in patient's brain.
   Google Scholar
• DINSMORE JH: Immunoprivileged sites for allo- and xe-notransplantation. In: Xenotransplantation. Cooper DKC et al. (Eds.), Springer-Verlag, New York, USA (1996):199–205.
   Google Scholar
• HUFFAKER TK et al.: Xenografting of foetal pig ventralmesencephalon corrects motor asymmetry in the rat model of Parkinson's disease. Exp. Brain Res. (1989) 77:329–336.
   PubMed Web of Science ®Google Scholar
• HANTRAYE P et al.: Intrastriatal transplantation of cross-species foetal striatal cells reduces abnormal movements in a primate model of Huntington's dis-ease. Proc. Natl. Acad. Sci. USA (1992) 89(9):4187–4191.
   PubMed Web of Science ®Google Scholar
• GALPERN WR et al.: Xenotransplantation of porcine foetal ventral mesencephalon in a rat model of Parkin-son's disease: functional recovery and graft morphol-ogy. Exp. Neurol. (1996) 140:1–13.
   PubMed Web of Science ®Google Scholar
• FREEMAN TB et al.: Cross-species intracerebral grafting of embryonic swine dopaminergic neurons. Prog. Brain Res. (1988) 78:473–477.
   PubMed Web of Science ®Google Scholar
• STRECKER RE eta].: Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as re-vealed by intracerebral dialysis. Neuroscience (1987) 22:169–178.
   Google Scholar
• GRASBON-FRODL EM et al.: Phenotypic development ofthe human embryonic striatal primordium: a study of the cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience (1996) 73 :171–183.
   PubMed Web of Science ®Google Scholar
• BRUNDIN P, FRICKER RA, NAKAO N: Paucity of P-zonesin striatal grafts prohibit commencement of clinical trials in Huntington's disease. Neuroscience (1996) 71:895–897.
   PubMed Web of Science ®Google Scholar
• NAIMI S et al.: Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult brain. Exp. Neurol (1996) 137:15–25.
   PubMed Web of Science ®Google Scholar
• AEBISCHER P eta].: Gene therapy for amyotrophic lat-eral sclerosis (ALS) using a polymer encapsulated xe-nogenic cell line engineered to secrete HCNTF. Human Gene Ther. (1996) 7(7):851–860.
   Google Scholar
• AEBISCHER P et al.: Encapsulation of neurotrophic factor-releasing cells for the treatment of neurodegen-erative diseases. Restorat. Neurol. Neurosci. (1995) 8(1-2):65–66.
   PubMed Web of Science ®Google Scholar
• SAGOT Y et al.: Polymer encapsulated cell lines geneti-cally engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Europ. j Neurosci. (1995) 7(6):1313–1322.
   PubMed Web of Science ®Google Scholar
• NAKAHARA Y, GAGE FH, TUSZYNSKI MH: Grafts of fi-broblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord. Cell Transplant. (1996) 5(2):191–204.
   PubMed Web of Science ®Google Scholar
• LINDNER MD et al. Implantation of encapsulated rate-cholamine and GDNF-producing cells in rats with uni-lateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. (1995) 132(0:62–76.
   PubMedGoogle Scholar
• KORDOWER JH et al.: Intrastriatal implants of polymer encapsulated cells genetically modified to secrete hu-man nerve growth factor - trophic effects upon © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(4) cholinergic and noncholinergic striatal neurons. Neu-roscience (1996) 72(1):63–77.
   Google Scholar
• HAMMANG JP et al.: Delivery of neurotrophic factors tothe CNS using encapsulated cells - developing treat-ments for neurodegenerative diseases. Cell Transplant. (1995) 4(Suppl 1):S27–S28.
   PubMedGoogle Scholar
• FRIM DM et al.: Implanted fibroblasts genetically engi-neered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to do-paminergic neurons in the rat. Proc. Natl. Acad. ScL USA (1994) 91(10:5104–5108.
   PubMedGoogle Scholar
• EMERICH DF et al.: Protective effect of encapsulatedcells producing neurotrophic factor cntf in a monkey model of Huntington's disease. Nature (1997) 386(6623)395–399.
   Google Scholar
• EMERICH DF et al: Cellular delivery of human CNTFprevents motor and cognitive dysfunction in a rodent model of Huntington's disease. Cell Transplant. (1997) 6(3)249–266.
   Google Scholar
• EMERICH DF et al. Implants of encapsulated human cntf-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. (1996) 16(16) 5168–5181
   PubMed Web of Science ®Google Scholar
• EMERICH DF et al. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res. (1996) 736(1-2):99–110.
   PubMed Web of Science ®Google Scholar
• EMERICH DF et al. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate - rescue and sprouting of degenerating cholinergic ba-sal forebrain neurons. J. ComparaL Neurol (1994) 349(1) 148–164
   PubMed Web of Science ®Google Scholar
• CALNE DB: Treatment of Parkinson's disease. New Engl J. Med. (1993) 29:1021–1027.
   Google Scholar
• TSUI JKC: Treatment of Parkinson's disease. In: Neuro-degenerative Diseases. Caine DB (Ed.), WB Saunders, Phila-delphia,USA (1994):573–582.
   Google Scholar
• STEECE-COLLIER K et al.: Chronic levodopa impairsmorphological development of grafted embryonic do-pamine neurons. Exp. Neurol. (1990) 110:201–208.
   PubMed Web of Science ®Google Scholar
• WALKINSHAW G, WATERS CM: Induction of apoptosisin catecholaminergic PC12 cells by L-DOPA: implica-tions for the treatment of Parkinson's disease. J. Clin. Invest. (1995) 95:2458–2464.
   PubMed Web of Science ®Google Scholar
• SUBRAMANIAN T et al. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and F-18-DOPA uptake and metabolism after in-tracerebral implantation in nonhuman primates. Cell Transplant (1997) 6(5):469–477.
   PubMed Web of Science ®Google Scholar
• EMERICH DF et al. Implantation of polymer- encapsulated human nerve growth factor-secreting fi-broblasts attenuates the behavioral and neuropa-thological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. (1994) 130(1):141–150.
   PubMed Web of Science ®Google Scholar
• YAN Q, ELLIOTT J, SNIDER WD: Brain-derived neuro-trophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature (1 9 9 2) 360(6400753–755.
   Google Scholar
• YAN Q, MATHESON C, LOPEZ OT: In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons [see comments]. Nature (1995) 373(6512):341–344.
   PubMed Web of Science ®Google Scholar
• TOMOZAW Y, APPEL SH: Soluble striatal extracts en-hance development of mesencephalic dopaminergic neurons in vitro. Brain Res. (1986) 399:111–124.
   PubMed Web of Science ®Google Scholar
• SCHNELL L et al.: Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature (1994) 367:170–173.
   PubMed Web of Science ®Google Scholar
• POULSEN KT eta].: TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron (1994) 13(0:1245–1252.
   Google Scholar
• LINDSAY RM et al: Neurotrophic factors: from mole-cule to man. Trends Neurosci. (1994) 17:182–190.
   PubMed Web of Science ®Google Scholar
• LIN LF et al.: GDNF: a glial cell line-derived neuro-trophic factor for midbrain dopaminergic neurons [see comments]. Science (1993) 260(5110:1130–1132.
   PubMedGoogle Scholar
• IP NY et al.: CNTF FGF and NGF collaborate to drive the terminal differentiation of MAH cells into postmitotic neurons. Neuron (1994) 13:443–455.
   PubMed Web of Science ®Google Scholar
• BANG AG, GOULDING MD: Regulation of vertebrate neural cell fate by transcription factors. Curr. Opin. Neurobiol (1996) 6:25–32.
   PubMed Web of Science ®Google Scholar
• AHMED S, REYNOLDS BA, WEISS S: BDNF enhances the differentiation but not the survival of CNS stem cell-derived neuronal precursors. J. Neurosci. (1995) 15(8)5765–5778.
   Google Scholar
• SAPORTA S eta].: Survival of rat and porcine sertoli cell transplants in the rat striatum without cyclosporine-a immunosuppression. Exp. Neurol (1997) 146(2)299–304.
   Google Scholar
• SAPORTA S et al.: Microcarrier enhanced survival of hu-man and rat foetal ventral mesencephalon cells im-planted in the rat striatum. Cell Transplant. (1997) 6:579–584.
   PubMed Web of Science ®Google Scholar
• MCKAY R: Stem cells in the central nervous system. Sci-ence (1997) 276:66–71.
   PubMed Web of Science ®Google Scholar
• BRUSTLE 0, MCKAY RDG: Neuronal progenitors as tools for cell replacement in the nervous system. (1996) 6:688-695.
   Google Scholar
• JOHE KK et al.: Single factors direct the differentiation of stem cells from the foetal and adult central nervous system. Genes Develop. (1996) 10:3129–3140.
   PubMed Web of Science ®Google Scholar
• ••This paper clearly demonstrates that single neuronal stemcells could be expanded in vitro and maintain the ability to differentiate into the three major cell types in the brain: glia, oligodendrocytes and neurones.
   Google Scholar
• KLEPPNER SR et al.: Transplanted human neurons de- rived from a teratocarcinoma cell line (NTera-2) ma-ture, integrate, and survive for over 1 year in the nude mouse brain. J. Comp. Neurol. (1995) 357:618-632. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs (1998) 7(4)
   Google Scholar
• KORDOWER JH et al.: Grafts of EGF-responsive neural stem cells derived from GFAP-HNGF transgenic mice - trophic and tropic effects in a rodent model of Huntington's disease. J. Comparat. Neurof (1997) 387 (1):96–113.
   PubMed Web of Science ®Google Scholar
• REYNOLDS BA, TETZLAFF W, WEISS S: A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. (1992) 12(104565–4574.
   Google Scholar
• ••First identification of neural stem cells.
   Google Scholar
• SNYDER EY et al.: Multipotent neural cell lines can en-graft and participate in development of mouse cere-bellum. Cell (1992) 68:33–51.
   PubMed Web of Science ®Google Scholar
• SNYDER EY, TAYLOR RM, WOLFE JH: Neural progenitor cell engraftment corrects lysosomal storage through-out the MPS VII mouse brain. Nature (1 99 5) 374(6520)367–370.
   Google Scholar
• TROJANOWSKI JQ et al.: In vivo and in vitro models of medulloblastomas and other primitive neuroectoder-mal brain tumors of childhood. Mol. Chem. Neuropathol. (1994) 21(2-0:219–239.
   PubMedGoogle Scholar
• WHITTEMORE SR, SNYDER EY: Physiological relevance and functional potential of central nervous system-derived cell lines. Mol. Neurobiol (1996) 12(0:13–38.
   PubMedGoogle Scholar
• PLEASURE SJ, LEE VM: NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. (1993) 35(0:585–602.
   PubMedGoogle Scholar
• SINDEN JD et al.: Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neu-roepithelial cell line into the ischaemia-lesioned hip-pocampus. Neuroscience (1997) 81:599–608.
   PubMed Web of Science ®Google Scholar